targeted therapy

September 7, 2021 · Richard L. Schilsky, MD, FACP, FSCT, FASCO
Algunas aprobaciones recientes de la Administración de Alimentos y Medicamentos (Food and Drug Administration, FDA) han hecho que las personas se enteren de que hay tratamientos agnósticos con respecto a los tumores. Pero, ¿qué significa eso y cómo podría beneficiar a alguien con cáncer? El director médico anterior (2013-2021) de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica), Richard L. Schilsky, aporta información sobre esta nueva forma de abordar el tratamiento del cáncer. Read More >>
2021 ASCO Annual Meeting; #ASCO21
August 5, 2021 · Brielle Gregory Collins, ASCO staff
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting in lung cancer, breast cancer, and sarcoma and describe what this research means for people with cancer. Read More >>
February 2, 2021 · Brielle Gregory Collins, ASCO staff
ASCO’s 2021 Advance of the Year highlights how progress in the treatment of gastrointestinal (GI) cancers is driven by molecular testing of tumors. Read More >>
October 20, 2020 · Brielle Gregory, ASCO staff
Dr. Neeraj Agarwal discusses 3 clinical trials presented at the 2020 ESMO Virtual Congress that studied new treatments for advanced kidney cancer, prostate cancer, and bladder cancer. Read More >>
ASCO20 Virtual Scientific Program; Research Round Up Podcast Series
June 23, 2020 · Claire Smith, ASCO staff
In this podcast, Cancer.Net Associate Editors share exciting research from the ASCO20 Virtual Scientific Program. Read More >>

Pages